Nanoviricides, Inc.
NNVC- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001379006
No open-market purchases or sales by Nanoviricides, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $3.27M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Nanoviricides, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- −2 vs. Q1 2022
- Shares held
- 1.11M
- −54.9K (−4.7%) vs. Q1 2022
- Total value
- $2.09M
- −$354.7K (−14.5%) vs. Q1 2022
- New holders
- 2
- 4 more added
- Sold out
- 4
- 7 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NNVC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 47 | $3.27M |
| Q1 2026 | 48 | $1.73M |
| Q4 2025 | 43 | $3.51M |
| Q3 2025 | 35 | $2.04M |
| Q2 2025 | 33 | $1.91M |
| Q1 2025 | 37 | $1.74M |
| Q4 2024 | 36 | $2.09M |
| Q3 2024 | 32 | $2.01M |
| Q2 2024 | 34 | $2.32M |
| Q1 2024 | 29 | $1.39M |
| Q4 2023 | 32 | $1.24M |
| Q3 2023 | 30 | $1.61M |
| Q2 2023 | 27 | $1.42M |
| Q1 2023 | 31 | $1.47M |
| Q4 2022 | 30 | $1.51M |
| Q3 2022 | 31 | $2.30M |
| Q2 2022 | 25 | $2.09M |
| Q1 2022 | 27 | $2.45M |
| Q4 2021 | 29 | $4.13M |
| Q3 2021 | 33 | $4.44M |
| Q2 2021 | 28 | $4.22M |
| Q1 2021 | 34 | $4.68M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Nanoviricides, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 427,878 | $804.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 160,948 | $302.0K | 0.00% | −28,548−15.1% | Reduced |
| Compagnie Lombard Odier SCmA | 150,000 | $282.0K | 0.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 110,100 | $206.0K | 0.00% | +1,600+1.5% | Added |
| Bridgeway Capital Management, LLC | 94,039 | $177.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 60,000 | $113.0K | 0.00% | −16,800−21.9% | Reduced |
| State Street Corp | 41,906 | $79.0K | 0.00% | +1,400+3.5% | Added |
| Northern Trust Corp | 18,494 | $35.0K | 0.00% | 00.0% | Unchanged |
| Wharton Business Group, LLC | 17,236 | $32.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 11,237 | $21.0K | 0.00% | −6,211−35.6% | Reduced |
| First Financial Bank - Trust Division | 10,881 | $20.0K | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 3,010 | $5.66K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 2,120 | $4.00K | 0.00% | −2,951−58.2% | Reduced |
| Tower Research Capital LLC (TRC) | 2,251 | $4.00K | 0.00% | −1,698−43.0% | Reduced |
| Cutler Group LP | 1,100 | $2.00K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 1,000 | $2.00K | 0.00% | +1,000 | New |
| TD Waterhouse Canada Inc. | 429 | $1.03K | 0.00% | 00.0% | Unchanged |
| IFP Advisors, Inc | 21 | $1.00K | 0.00% | −28−57.1% | Reduced |
| Prospera Financial Services Inc | 450 | $1.00K | 0.00% | 00.0% | Unchanged |
| Clearstead Advisors, LLC | 293 | $1.00K | 0.00% | +293 | New |
| Morgan Stanley | 123 | $0 | 0.00% | −637−83.8% | Reduced |
| US Bancorp | 50 | $0 | 0.00% | +7+16.3% | Added |
| Bank of America Corp | 100 | $0 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 270 | $0 | 0.00% | +50+22.7% | Added |
| Tfo-TDC, LLC | 65 | $0 | 0.00% | 00.0% | Unchanged |
| Alaethes Wealth LLC | 0 | $0 | 0.00% | −2,133−100.0% | Sold out |
| Sandy Spring Bank | 0 | $0 | 0.00% | −265−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Glassman Wealth Services | 0 | $0 | 0.00% | −1−100.0% | Sold out |